The Hype Behind Peptides: Is There Any Truth Behind It?

Peptides seem to be everywhere at the moment. Read more thoughts on The Hype Behind Peptides: Is There Any Truth Behind It?

Scroll through social media and you may come across claims that peptide injections can speed up injury recovery, repair tendons, build muscle, reduce body fat, improve energy and even slow down ageing.

For someone struggling with a stubborn tendon injury, joint pain or a slow recovery, the promise is understandably attractive. But how much of this is backed by good science, and how much is simply hype?

The answer is not quite black and white.

First, what exactly is a peptide?

Peptides are small chains of amino acids — the same building blocks that make up proteins. Our bodies naturally produce thousands of different peptides, many of which act as chemical messengers controlling processes such as hormones, inflammation, digestion, tissue repair and metabolism.

So peptides themselves are certainly not pseudoscience.

In fact, some very important medicines are peptide-based. Insulin is a peptide, while modern GLP-1 medications used to treat diabetes and obesity are another well-known example. These medicines have undergone extensive clinical testing to establish how well they work, what dose should be used and what side effects patients need to be aware of.

The important question therefore isn’t whether peptides work. Some clearly do. The question is whether the particular peptide being promoted has actually been proven to work for the particular condition it claims to treat.

Where does the current peptide hype come from?

Much of the excitement is centred around injectable compounds with names such as BPC-157, TB-500, CJC-1295 and ipamorelin.

They are being promoted for everything from faster muscle and tendon healing to fat loss, improved athletic performance and anti-ageing.

For orthopaedic patients, BPC-157 and TB-500 are particularly interesting because of claims that they can accelerate the healing of tendons, ligaments, muscles and other soft tissues.

This is where we need to separate promising science from proven treatment.

What does the science actually say about injury healing?

There is some interesting early research.

BPC-157, for example, has produced encouraging results in laboratory and animal studies involving tendon, ligament and muscle healing. Researchers have identified biological effects that could potentially play a role in tissue repair.

But there is a very large difference between something helping an injured tendon in a laboratory animal and demonstrating that it safely and reliably improves recovery in people.

Human evidence for BPC-157 remains extremely limited. Recent reviews have found only a handful of very small human studies, with no large, high-quality clinical trials establishing that BPC-157 safely speeds up tendon, ligament or muscle healing.

TB-500 has even less clinical evidence. The US Food and Drug Administration (FDA) states that it has not identified human exposure data for the TB-500 fragment it has assessed and does not have enough information to determine its safety. The FDA similarly says that safety information for BPC-157 is limited and insufficient to know whether it may cause harm when administered to humans.

So, while there may be scientific reasons to continue researching these substances, that is very different from saying we currently have a proven treatment.

“But people online say it worked for them”

This is one of the difficulties with many new treatments.

Someone may take a peptide after an injury and recover remarkably well. The temptation is then to credit the peptide.

But many tendon, muscle and ligament injuries improve naturally over time, particularly when combined with rest, rehabilitation, physiotherapy and a gradual return to activity.

Without controlled clinical studies comparing similar groups of patients, it is extremely difficult to know whether someone recovered because of the peptide or simply while using the peptide.

Personal success stories can be interesting, but they are not a substitute for clinical evidence.

There is another concern: what is actually in the injection?

With an approved medicine, manufacturing is tightly controlled. Doctors know the active ingredient, its concentration, recommended dosage and known safety profile.

The same cannot necessarily be said for peptides purchased through websites, social media, gyms or informal wellness suppliers.

This has become enough of a concern in South Africa that SAHPRA issued a public warning in May 2026 about unregistered peptide products, specifically naming BPC-157, TB-500, CJC-1295, ipamorelin and several others. SAHPRA warns that these products are being promoted for injury recovery, muscle growth, anti-ageing and enhanced performance without having been evaluated and approved for safety, quality and effectiveness.

When something is being injected into the body, questions around sterility, contamination, concentration and manufacturing quality become particularly important.

There is also the bigger problem that we do not yet know the long-term consequences of using many of these experimental compounds in humans.

Does that mean peptides are a dead end?

Not at all.

Peptide medicine is actually a very exciting area of research. Around 100 peptide therapeutics have already received FDA approval for various medical conditions, and many more are being investigated.

It is entirely possible that some of today’s experimental peptides will eventually prove useful in orthopaedics and sports medicine.

BPC-157 is a good example. The laboratory research is interesting enough that further human trials are justified. But until those trials have been done, we simply don’t know whether the benefits seen in experimental research translate into meaningful improvements for patients — or what risks might emerge when larger numbers of people use it.

Promising is not the same as proven.

So, is there any truth behind the peptide hype?

Yes — but perhaps not in the way social media would have us believe.

Peptides are real biological molecules, peptide medicines already play an important role in modern healthcare, and there is exciting research taking place into their future use.

However, the enormous leap from “this peptide showed interesting effects in a laboratory” to “inject this and your tendon will heal faster” is where much of the current hype gets ahead of the evidence.

For patients dealing with an injury, the attraction of a shortcut is understandable. But before injecting an experimental product, it is worth asking some basic questions:

Has this particular peptide been properly tested in humans?
Has it been proven to work for my particular condition?
Do we know the appropriate dose?
Do we know the short- and long-term risks?
And do we know exactly what is contained in the product being supplied?

For many of the peptides currently being marketed for musculoskeletal recovery, we cannot yet confidently answer those questions.

That doesn’t mean the science won’t eventually get there.

It simply means that, for now, the hype is running considerably faster than the evidence.

This article “The Hype Behind Peptides: Is There Any Truth Behind It?” does not provide medical advice and is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Please consult a doctor for all medical advice.

Sources:

https://www.health.harvard.edu/

https://med.stanford.edu/